- Home
- CERS vs IMMR Comparison
CERS vs IMMR Comparison
Compare CERS & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- IMMR
- Stock Information
- Founded
- CERS 1991
- IMMR 1993
- Country
- CERS United States
- IMMR United States
- Employees
- CERS N/A
- IMMR N/A
- Industry
- CERS EDP Services
- IMMR Computer peripheral equipment
- Sector
- CERS Technology
- IMMR Technology
- Exchange
- CERS Nasdaq
- IMMR Nasdaq
- Market Cap
- CERS 255.0M
- IMMR 251.7M
- IPO Year
- CERS 1997
- IMMR 1999
- Fundamental
- Price
- CERS $1.30
- IMMR $7.13
- Analyst Decision
- CERS Strong Buy
- IMMR Strong Buy
- Analyst Count
- CERS 2
- IMMR 2
- Target Price
- CERS $3.50
- IMMR $12.25
- AVG Volume (30 Days)
- CERS 1.2M
- IMMR 353.8K
- Earning Date
- CERS 10-29-2025
- IMMR 09-11-2025
- Dividend Yield
- CERS N/A
- IMMR 2.52%
- EPS Growth
- CERS N/A
- IMMR 57.07
- EPS
- CERS N/A
- IMMR 2.04
- Revenue
- CERS $192,510,000.00
- IMMR $163,133,000.00
- Revenue This Year
- CERS $30.03
- IMMR $988.71
- Revenue Next Year
- CERS $9.37
- IMMR $109.72
- P/E Ratio
- CERS N/A
- IMMR $3.49
- Revenue Growth
- CERS 13.25
- IMMR 338.21
- 52 Week Low
- CERS $1.12
- IMMR $6.47
- 52 Week High
- CERS $2.24
- IMMR $10.72
- Technical
- Relative Strength Index (RSI)
- CERS 50.21
- IMMR 51.57
- Support Level
- CERS $1.26
- IMMR $6.91
- Resistance Level
- CERS $1.35
- IMMR $7.07
- Average True Range (ATR)
- CERS 0.07
- IMMR 0.13
- MACD
- CERS 0.01
- IMMR 0.03
- Stochastic Oscillator
- CERS 51.72
- IMMR 87.88
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.